Clinical Research - SPC Subcommittee

FASEB : OPA : Policy Issues

Clinical Research Subcommittee

Go Back

The mission of the Clinical Research Subcommittee is to represent the FASEB member societies on policy issues related to clinical research. Relevant activities for this subcommittee may include, but are not limited to, training, funding, workforce and regulatory issues, and education of scientists and the public as they relate to clinical research. Policy statements and projects related to these issues may stem from the interests of subcommittee members or develop in response to relevant issues as they arise. The Clinical Research Subcommittee will work closely with other committees and subcommittees on issues that are important to the entire research enterprise, such as training and research funding.

Members of the Clinical Research Subcommittee:


	Richard Galbraith, M.D., Ph.D. Chair (ASN) Felicia Cosman, M.D., (ASBMR) Janet Hall, M.D. (ENDO) James Musser, M.D., Ph.D. (ASIP) Michael Portman, M.D. (APS) Jane Reusch, M.D. (ENDO) Ronnen Roubenoff, M.D., M.H.S. (ASN) Peter Rubenstein, Ph.D. (ASBMB) Nanette Santoro, M.D. (SGI/ENDO) John Smith, M.D., Ph.D. (ApepS) Dani Zander, M.D. (ASIP) Jennifer A. Hobin, Ph.D. (FASEB Staff Liaison)
>Related Resources

The Federation of American Societies for Experimental Biology (FASEB) advances biological science through collaborative advocacy for research policies that promote scientific progress and education and lead to improvements in human health.